-
1
Immune‐dysregulation harnessing in myeloid neoplasms
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
2
The combination of a tyrosine kinase inhibitor and blinatumomab in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia or Philadelphia chromosome‐like acute...
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
3
A video intervention to improve patient understanding of tumor genomic testing in patients with cancer
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
4
Mental health in people living with and beyond colorectal cancer: A patient‐oriented constructivist grounded theory
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
5
Global, regional, and national burdens of leukemia from 1990 to 2019: A systematic analysis of the global burden of disease in 2019 based on the APC model
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
6
RETRACTED: LncRNA CCAT2 promotes the proliferation and metastasis of colorectal cancer through activation of the ERK and Wnt signaling pathways by regulating GNB2 expression
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
7
Potential therapeutic effects of apigenin for colorectal adenocarcinoma: A systematic review and meta‐analysis
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
8
Gender and melanoma subtype‐based prognostic implications of MUC16 and TTN co‐occurrent mutations in melanoma: A retrospective multi‐study analysis
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
9
Inosine enhances the efficacy of immune‐checkpoint inhibitors in advanced solid tumors: A randomized, controlled, Phase 2 study
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
10
Nomograms for predicting recurrence of HER2‐positive breast cancer with different HR status based on ultrasound and clinicopathological characteristics
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
11
Evaluating implementation of a hospital‐based cancer registry to improve childhood cancer care in low‐ and middle‐income countries
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
12
Radiomic prediction for durable response to high‐dose methotrexate‐based chemotherapy in primary central nervous system lymphoma
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
13
Serum matrix metalloproteinase‐7, Syndecan‐1, and CA 19‐9 as a biomarker panel for diagnosis of pancreatic ductal adenocarcinoma
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
14
Poor outcome despite modern treatments: A retrospective study of 99 patients with primary and secondary plasma cell leukemia
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
15
The impact of margins and re‐resection in pediatric synovial sarcoma
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
16
The COVID‐19 pandemic and associated declines in cancer incidence by race/ethnicity and census‐tract level SES, rurality, and persistent poverty status
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
17
Tumor volume changes after stereotactic, hypofractionated and conventional radiotherapy in paragangliomas of head and neck
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
18
Identification of novel pQTL‐SNPs associated with lung adenocarcinoma risk: A multi‐stage study
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
19
Building on and tailoring to: Adapting a cancer caregiver psychoeducational intervention for rural settings
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article -
20
The prognosis and metabolite changes of NSCLC patients receiving first‐line immunotherapy combined chemotherapy in different M1c categories according to 9th edition of TNM classifi...
Published 2024-09-01“…Cancer Medicine…”
Get full text
Article